TL;DR: A 2026 randomized pilot trial in the Journal of Affective Disorders found that 30 minutes of moderate exercise before cognitive behavioral therapy (CBT) for major depressive disorder was linked to stronger therapy-process measures and higher exploratory remission than quiet rest before CBT. Key Findings Forty adults with major depressive disorder were randomized: Nineteen received …
TL;DR: A 2026 medRxiv preprint used single photon emission computed tomography (SPECT), a brain blood-flow imaging method, and a 68-component NeuroMark template to link depression-related symptoms with frontal, subcortical, cerebellar, salience, and visual network patterns across several psychiatric groups. Key Findings Large imaging pool: Researchers analyzed 2,743 patient SPECT scans with clinical data plus 76 …
TL;DR: A 2026 systematic review and meta-analysis posted to medRxiv found that gamma-frequency non-invasive brain stimulation was linked to symptom improvement in schizophrenia and depressive-symptom reduction in major depressive disorder, but the evidence was heterogeneous and still preprint-level. Key Findings 56 controlled studies were included across schizophrenia, major depressive disorder, bipolar disorder, and autism spectrum …
TL;DR: A 2026 study in Brain, Behavior, & Immunity – Health found that whole-body hyperthermia in adults with major depressive disorder triggered a 30-minute whole-blood RNA-seq response dominated by heat-shock genes and immune pathways, including IL-6 production. Key Findings 18 RNA-seq participants: Whole-blood RNA sequencing was available for 9 adults assigned to whole-body hyperthermia and …
TL;DR: A 2026 systematic review and meta-analysis in Acta Neuropsychiatrica found no clear evidence that parenteral clomipramine is better than oral clomipramine for depression or obsessive-compulsive disorder, with low or very low certainty across the main randomized-trial evidence. Key Findings 4,973 publications screened: The review identified 14 randomized controlled trials relevant to parenteral clomipramine in …
TL;DR: A 2026 case-series study in Translational Psychiatry tested delayed-release oral acetate from apple cider vinegar capsules in 11 young adults taking psychotropic medications and found high adherence, no product-related adverse events, microbiome shifts, and metabolic improvement in 6 participants, but the uncontrolled design means the findings need placebo-controlled testing. Key Findings 11 completers: The …
TL;DR: A 2026 mouse study in Cell traced ketamine’s rapid antidepressant-like effect to mu-opioid receptors on somatostatin-positive interneurons in the medial prefrontal cortex. Low-dose multi-GPCR targeting reproduced ketamine-like effects in mice, but the exact three compound names were not listed in the public source material verified here. Key Findings Cell target: ketamine’s rapid mouse effect …
TL;DR: A 2026 biomarker analysis in Brain, Behavior, & Immunity – Health across antidepressant trials found that kynurenine pathway metabolites were elevated in inflammatory depression compared with non-inflammatory depression and healthy controls, while omega-3 polyunsaturated fatty acid treatment reduced several kynurenine pathway metabolites. Key Findings Study type: a combined analysis of two depression trials testing …
TL;DR: A 2026 cross-sectional NHANES analysis in Depression and Anxiety found that urinary pyrethroid metabolite 3-PBA showed a dose-dependent association with depression, while female participants showed stronger associations for 3-PBA and 4F-3-PBA, while males showed sensitivity to DCBA in mixture models. Key Findings Study type: a survey-weighted analysis using self-reported pesticide exposure and urinary pesticide …
TL;DR: A 2026 preprint deep brain stimulation biomarker study in medRxiv found that home-recorded electrophysiology biomarkers tracked stable depression recovery during SCC DBS, while the biomarkers helped distinguish recovery from nonspecific symptom fluctuations and external distress. Key Findings Study type: a home-recording study using bidirectional deep brain stimulation devices to monitor electrophysiology during depression recovery. …
